News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
717,237 Results
Type
Article (42131)
Company Profile (267)
Press Release (674838)
Multimedia
Podcasts (65)
Webinars (15)
Section
Business (207524)
Career Advice (2054)
Deals (35861)
Drug Delivery (100)
Drug Development (81707)
Employer Resources (173)
FDA (16443)
Job Trends (15104)
News (350077)
Policy (32944)
Tag
Academia (2675)
Academic (1)
Accelerated approval (11)
Adcomms (22)
Allergies (96)
Alliances (50948)
ALS (111)
Alzheimer's disease (1466)
Antibody-drug conjugate (ADC) (153)
Approvals (16438)
Artificial intelligence (335)
Autoimmune disease (29)
Automation (19)
Bankruptcy (362)
Best Places to Work (11808)
BIOSECURE Act (19)
Biosimilars (124)
Biotechnology (188)
Bladder cancer (95)
Brain cancer (34)
Breast cancer (369)
Cancer (2913)
Cardiovascular disease (215)
Career advice (1721)
Career pathing (30)
CAR-T (187)
CDC (31)
Cell therapy (509)
Cervical cancer (22)
Clinical research (67201)
Collaboration (1046)
Company closure (3)
Compensation (692)
Complete response letters (23)
COVID-19 (2663)
CRISPR (59)
C-suite (341)
Cystic fibrosis (113)
Data (3031)
Decentralized trials (2)
Denatured (24)
Depression (62)
Diabetes (347)
Diagnostics (6628)
Digital health (24)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (142)
Drug pricing (122)
Drug shortages (28)
Duchenne muscular dystrophy (131)
Earnings (87989)
Editorial (41)
Employer branding (21)
Employer resources (149)
Events (115399)
Executive appointments (866)
FDA (18128)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (953)
Gene editing (135)
Generative AI (25)
Gene therapy (383)
GLP-1 (790)
Government (4562)
Grass and pollen (4)
Guidances (182)
Healthcare (19182)
HIV (41)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (148)
Immuno-oncology (9)
Indications (39)
Infectious disease (2838)
Inflammatory bowel disease (149)
Inflation Reduction Act (10)
Influenza (63)
Intellectual property (121)
Interviews (318)
IPO (16697)
IRA (45)
Job creations (3683)
Job search strategy (1457)
Kidney cancer (13)
Labor market (53)
Layoffs (501)
Leadership (19)
Legal (7970)
Liver cancer (80)
Longevity (12)
Lung cancer (405)
Lymphoma (209)
Machine learning (11)
Management (59)
Manufacturing (400)
MASH (92)
Medical device (13704)
Medtech (13709)
Mergers & acquisitions (19897)
Metabolic disorders (854)
Multiple sclerosis (98)
NASH (16)
Neurodegenerative disease (118)
Neuropsychiatric disorders (32)
Neuroscience (2153)
NextGen: Class of 2025 (6673)
Non-profit (4600)
Now hiring (48)
Obesity (428)
Opinion (222)
Ovarian cancer (101)
Pain (107)
Pancreatic cancer (123)
Parkinson's disease (188)
Partnered (22)
Patents (307)
Patient recruitment (168)
Peanut (51)
People (58779)
Pharmaceutical (63)
Pharmacy benefit managers (21)
Phase I (20986)
Phase II (29596)
Phase III (22003)
Pipeline (1652)
Policy (203)
Postmarket research (2577)
Preclinical (9031)
Press Release (68)
Prostate cancer (141)
Psychedelics (37)
Radiopharmaceuticals (262)
Rare diseases (464)
Real estate (6042)
Recruiting (66)
Regulatory (22918)
Reports (50)
Research institute (2431)
Resumes & cover letters (354)
Rett syndrome (9)
RNA editing (8)
RSV (49)
Schizophrenia (86)
Series A (160)
Series B (110)
Service/supplier (11)
Sickle cell disease (61)
Special edition (18)
Spinal muscular atrophy (151)
Sponsored (33)
Startups (3664)
State (2)
Stomach cancer (14)
Supply chain (76)
Tariffs (59)
The Weekly (39)
Vaccines (787)
Venture capital (54)
Weight loss (258)
Women's health (48)
Worklife (17)
Date
Today (84)
Last 7 days (372)
Last 30 days (1838)
Last 365 days (31544)
2025 (17155)
2024 (35625)
2023 (40575)
2022 (51675)
2021 (56277)
2020 (54840)
2019 (47547)
2018 (35740)
2017 (32701)
2016 (32117)
2015 (38225)
2014 (31855)
2013 (27020)
2012 (29209)
2011 (29902)
2010 (27893)
Location
Africa (745)
Alabama (62)
Alaska (7)
Arizona (244)
Arkansas (13)
Asia (39266)
Australia (6397)
California (7534)
Canada (2376)
China (684)
Colorado (321)
Connecticut (320)
Delaware (197)
Europe (85229)
Florida (1131)
Georgia (252)
Hawaii (1)
Idaho (60)
Illinois (648)
India (29)
Indiana (365)
Iowa (18)
Japan (232)
Kansas (110)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1044)
Massachusetts (5604)
Michigan (249)
Minnesota (462)
Mississippi (3)
Missouri (91)
Montana (29)
Nebraska (25)
Nevada (82)
New Hampshire (67)
New Jersey (2103)
New Mexico (29)
New York (2110)
North Carolina (1101)
North Dakota (9)
Northern California (3306)
Ohio (240)
Oklahoma (16)
Oregon (35)
Pennsylvania (1624)
Puerto Rico (17)
Rhode Island (36)
South America (1133)
South Carolina (35)
South Dakota (1)
Southern California (2820)
Tennessee (128)
Texas (1149)
United States (27943)
Utah (222)
Virginia (189)
Washington D.C. (73)
Washington State (641)
West Virginia (4)
Wisconsin (67)
717,237 Results for "integral molecular inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Clinical Genomics Market Surges in 2025 with NABL-Accredited Molecular Labs and AI-Integrated Platforms
July 1, 2025
·
1 min read
Press Releases
Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville
June 17, 2025
·
8 min read
Collaboration
Genentech Bets Again on Orionis With Potential $2B+ in Crowded Molecular Glue Space
Roche, along with Bristol Myers Squibb, Novo Nordisk, AbbVie, Eli Lilly and others, is making inroads into molecular glues to use in cancer, immunology and other applications.
May 21, 2025
·
2 min read
·
Tristan Manalac
Collaboration
Lilly Hops On Hot Molecular Glue Train With $1.2B+ Magnet Deal
The molecular glue space has attracted several Big Pharma players over the past few years, including Novo Nordisk, Pfizer and Novartis.
February 28, 2025
·
2 min read
·
Tristan Manalac
Business
Integrated DNA Technologies and Molecular Health Ink Commercial Partnership
Genomics solutions provider Integrated DNA Technologies (IDT) and Bio-IT company Molecular Health have entered into a global multi-year agreement, starting in the U.S., to integrate their next generation sequencing (NGS) capabilities.
May 15, 2024
·
6 min read
Press Releases
Pion Inc. Announces DissoSpec Fully Integrated Dissolution System
May 27, 2025
·
2 min read
Pharm Country
Integral Molecular Launches Virus Neutralization Assay Services to Drive Antiviral Discovery
Integral Molecular announces the launch of its Virus Neutralization Assay Services enabling researchers to rapidly obtain high-quality data to advance their vaccines and therapeutic antibodies.
April 16, 2024
·
2 min read
Press Releases
Exact Sciences Announces Medicare Coverage for Oncodetect™ Molecular Residual Disease Test in Colorectal Cancer
July 9, 2025
·
4 min read
Lone Star Bio
Molecular Templates, Inc. Provides Interim Update
Molecular Templates, Inc. today provided an update on its clinical-stage programs.
June 3, 2024
·
7 min read
Press Releases
QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics
June 4, 2025
·
8 min read
1 of 71,724
Next
